Published in J Hosp Med on January 05, 2011
Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA (2013) 5.27
Functional impairment and hospital readmission in Medicare seniors. JAMA Intern Med (2015) 3.37
Impact of social factors on risk of readmission or mortality in pneumonia and heart failure: systematic review. J Gen Intern Med (2012) 2.67
Hospital readmission performance and patterns of readmission: retrospective cohort study of Medicare admissions. BMJ (2013) 2.36
Is the readmission rate a valid quality indicator? A review of the evidence. PLoS One (2014) 1.56
Unplanned Readmissions After Hospitalization for Severe Sepsis at Academic Medical Center-Affiliated Hospitals. Crit Care Med (2015) 1.50
Quality of care in the US territories. Arch Intern Med (2011) 1.49
Sex Differences in the Rate, Timing, and Principal Diagnoses of 30-Day Readmissions in Younger Patients with Acute Myocardial Infarction. Circulation (2015) 1.44
Variation exists in rates of admission to intensive care units for heart failure patients across hospitals in the United States. Circulation (2013) 1.37
Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 1.36
Community factors and hospital readmission rates. Health Serv Res (2014) 1.29
Association of self-reported hospital discharge handoffs with 30-day readmissions. JAMA Intern Med (2013) 1.28
Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study. BMJ (2015) 1.26
Functional Status Outperforms Comorbidities in Predicting Acute Care Readmissions in Medically Complex Patients. J Gen Intern Med (2015) 1.24
Income inequality and 30 day outcomes after acute myocardial infarction, heart failure, and pneumonia: retrospective cohort study. BMJ (2013) 1.23
Based on key measures, care quality for Medicare enrollees at safety-net and non-safety-net hospitals was almost equal. Health Aff (Millwood) (2012) 1.23
Survival after acute myocardial infarction (SAMI) study: the design and implementation of a positive deviance study. Am Heart J (2011) 1.19
Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004-2011. Open Heart (2014) 1.14
Development and use of an administrative claims measure for profiling hospital-wide performance on 30-day unplanned readmission. Ann Intern Med (2014) 1.05
Readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia among young and middle-aged adults: a retrospective observational cohort study. PLoS Med (2014) 1.03
Utility of models to predict 28-day or 30-day unplanned hospital readmissions: an updated systematic review. BMJ Open (2016) 0.91
Outcomes for mitral valve surgery among Medicare fee-for-service beneficiaries, 1999 to 2008. Circ Cardiovasc Qual Outcomes (2012) 0.91
High-performance detection and early prediction of septic shock for alcohol-use disorder patients. Ann Med Surg (Lond) (2016) 0.91
Procedure intensity and the cost of care. Circ Cardiovasc Qual Outcomes (2012) 0.90
Correlations among risk-standardized mortality rates and among risk-standardized readmission rates within hospitals. J Hosp Med (2012) 0.90
The management of community-acquired pneumonia in the elderly. Eur J Intern Med (2013) 0.88
Pediatric readmission classification using stacked regularized logistic regression models. AMIA Annu Symp Proc (2014) 0.88
Hospitalist utilization and hospital performance on 6 publicly reported patient outcomes. J Hosp Med (2012) 0.86
Thirty-day hospital readmissions for adults with and without HIV infection. HIV Med (2015) 0.81
Risk-standardized Acute Admission Rates Among Patients With Diabetes and Heart Failure as a Measure of Quality of Accountable Care Organizations: Rationale, Methods, and Early Results. Med Care (2016) 0.78
National trends in stroke after acute myocardial infarction among Medicare patients in the United States: 1999 to 2010. Am Heart J (2014) 0.77
Predictors of rehospitalization after admission for pneumonia in the veterans affairs healthcare system. J Hosp Med (2014) 0.77
Predictors and impact of thirty-day readmission on patient outcomes and health care costs after reduced-toxicity conditioning allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2013) 0.77
Treatment for Multiple Acute Cardiopulmonary Conditions in Older Adults Hospitalized with Pneumonia, Chronic Obstructive Pulmonary Disease, or Heart Failure. J Am Geriatr Soc (2016) 0.77
Relationship Between Age and Trajectories of Rehospitalization Risk in Older Adults. J Am Geriatr Soc (2016) 0.76
Predicting the Risk of Readmission in Pneumonia. A Systematic Review of Model Performance. Ann Am Thorac Soc (2016) 0.75
Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Integrated precision medicine: the role of electronic health records in delivering personalized treatment. Wiley Interdiscip Rev Syst Biol Med (2017) 0.75
Trajectories of Risk for Specific Readmission Diagnoses after Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia. PLoS One (2016) 0.75
Half of 30-Day Hospital Readmissions Among HIV-Infected Patients Are Potentially Preventable. AIDS Patient Care STDS (2015) 0.75
Predicting Readmission at Early Hospitalization Using Electronic Clinical Data: An Early Readmission Risk Score. Med Care (2016) 0.75
Sex Differences in Trajectories of Risk After Rehospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia. Circ Cardiovasc Qual Outcomes (2017) 0.75
Screening for serious mental illness in the general population. Arch Gen Psychiatry (2003) 15.75
Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA (2004) 14.05
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA (2008) 12.36
Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med (2009) 11.51
Telemonitoring in patients with heart failure. N Engl J Med (2010) 10.82
Public reporting and pay for performance in hospital quality improvement. N Engl J Med (2007) 10.55
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54
Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med (2008) 8.36
Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med (2006) 8.18
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA (2007) 7.12
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med (2009) 6.89
Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study. Lancet (2012) 6.60
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ (2012) 6.39
An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes (2008) 6.00
The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med (2005) 5.86
Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med (2002) 5.74
Trends in survival after in-hospital cardiac arrest. N Engl J Med (2012) 5.67
Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes (2009) 5.66
Pay for performance in commercial HMOs. N Engl J Med (2006) 5.52
Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med (2005) 5.49
An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation (2006) 5.35
Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA (2013) 5.27
National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA (2011) 5.16
Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA (2003) 5.09
Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06
Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA (2002) 4.92
Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med (2002) 4.80
Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation (2007) 4.74
National trends in use of computed tomography in the emergency department. Ann Emerg Med (2011) 4.72
The ADVANTAGE seeding trial: a review of internal documents. Ann Intern Med (2008) 4.70
An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation (2006) 4.52
Regulatory review of novel therapeutics--comparison of three regulatory agencies. N Engl J Med (2012) 4.50
Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med (2002) 4.45
Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 4.39
Consequences of inadequate sign-out for patient care. Arch Intern Med (2008) 4.39
Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA (2003) 4.38
Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA (2010) 4.36
Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation (2006) 4.35
Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA (2009) 4.29
Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA (2009) 4.24
Physician clinical performance assessment: prospects and barriers. JAMA (2003) 4.16
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol (2004) 4.14
Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11
Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes. Arch Intern Med (2012) 4.02
Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail (2009) 3.95
Time to treatment in primary percutaneous coronary intervention. N Engl J Med (2007) 3.95
Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ (2005) 3.94
Long-term outcomes in elderly survivors of in-hospital cardiac arrest. N Engl J Med (2013) 3.85
Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol (2006) 3.85
When choosing statin therapy: the case for generics. JAMA Intern Med (2013) 3.80
Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation (2005) 3.78
Behavioral health insurance parity for federal employees. N Engl J Med (2006) 3.77
Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med (2007) 3.71
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70
Variability in the measurement of hospital-wide mortality rates. N Engl J Med (2010) 3.65
Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation (2012) 3.61
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation (2006) 3.45
Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA (2004) 3.45
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg (2009) 3.45
Transfers of patient care between house staff on internal medicine wards: a national survey. Arch Intern Med (2006) 3.43
Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med (2008) 3.42
Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA (2006) 3.40